Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lilly Among MNCs Scouting In Turkey For Local Partners As GMP Inspection Backlog Continues

This article was originally published in PharmAsia News

Executive Summary

Eli Lilly & Co. Inc. has been rumored to be in partnership talks with Turkish Mustafa Nevzat Pharmaceuticals. The U.S. drug maker is reportedly looking for a minority stake in the Turkish generics maker

You may also be interested in...



IEIS Secretary General Turgut Tokgoz On The Future Of Turkish Pharma: An Interview With PharmAsia News (Part 2 of 2)

In the midst of negotiations over the government’s next pharmaceutical budget, the leader of the Pharmaceutical Manufacturers Association of Turkey sits down to talk about price cuts, GMP requirements and the future of the Turkish pharma industry.

IEIS Secretary General Turgut Tokgoz On The Future Of Turkish Pharma: An Interview With PharmAsia News (Part 1 of 2)

In the midst of negotiations over the government’s next pharmaceutical budget, the leader of the Pharmaceutical Manufacturers Association of Turkey sits down to talk about price cuts, GMP requirements and the future of the Turkish pharma industry.

Amgen Shrugs Off Turkish Price Cuts, Snatches Up Mustafa Nevzat For Broader Reach Into Emerging Markets

Despite harsh price cuts in Turkey that have taken a toll on multinationals, Amgen dives head first into the market.

Related Content

Latest News
See All
UsernamePublicRestriction

Register

SC076410

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel